Evidence map›Paper›PMID 41333581›Full record

ArticleJugan geon-gang gwa jilbyeong2023

[Co-infection of Severe Acute Respiratory Syndrome Coronavirus 2 and Other Viral Respiratory Pathogens in the Republic of Korea].

Jaehee Lee, Nam-Joo Lee, SangHee Woo, Jee Eun Rhee, Eun-Jin Kim

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jaehee Lee질병관리청 감염병진단분석국 신종병원체분석과.
Nam-Joo Lee질병관리청 감염병진단분석국 신종병원체분석과.
SangHee Woo질병관리청 감염병진단분석국 신종병원체분석과.
Jee Eun Rhee질병관리청 감염병진단분석국 신종병원체분석과.
Eun-Jin Kim질병관리청 감염병진단분석국 신종병원체분석과.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), is co-infection with other respiratory viruses can negatively affect the patient's clinical condition and cause difficulty in breathing, comorbidities, and increased mortality risk. Hence, the Korea Centers for Disease Control and Prevention Agency analyzed the co-infection rate of respiratory viruses, such as influenza, and the distribution by age groups in domestic COVID-19 patients. Co-infection with one or more respiratory viruses was confirmed in 104 (2.0%) of 5,171 COVID-19-positive samples collected from January to December 2022. The detection rate of co-infection with respiratory pathogens was highest at 15.8% in the age group of 0-6 years. The immature immune system of children and environmental resistance of non-enveloped viruses may have contributed to the high co-infection detection rate. As the spread of respiratory viruses is increasing due to relaxation of the COVID-19 restrictions and co-infections are expected to increase, we will continue to monitor co-infections of SARS-CoV-2 and other respiratory viruses closely.

Indexed as

Co-infectionCoronavirus disease 2019Respiratory virus

Identifiers

PMID41333581
PMCPMC12479728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.